article Open AccessTop 10% cited
Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis
Lara D. Veeken · 2012 · Vol. 51(9) · pp. 1563–1570
Takahisa Gono✉Shoichiro Sato(Tokai University)Yasushi Kawaguchi(Tokai University)Masataka Kuwana(Tokai University)Masanori Hanaoka(Tokai University)Yasuhiro Katsumata(Tokai University)K. Takagi(Tokai University)S. Baba(Tokai University)Yuko Okamoto(Tokai University)Yuko Ota(Tokai University)Hisashi Yamanaka(Tokai University)
Abstract
Anti-MDA5ab titre and ferritin and IL-18 concentrations are useful for the evaluation of the response to treatment and the status of ILD in patients with anti-MAD5ab-positive DM.
Inflammatory Myopathies and DermatomyositisEosinophilic Disorders and SyndromesInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicineFerritinInterstitial lung diseaseGastroenterologyInternal medicineDermatomyositisMalignancyComplicationAntibodyLung
MeSH terms
Interferon-Induced Helicase, IFIH1AutoantibodiesDermatomyositisDrug Therapy, CombinationFemaleFerritinsGlucocorticoidsHumansJapanMaleMiddle AgedPrednisolonePrognosisRetrospective StudiesSurvival Rate
Citations
330
FWCI
6.37
field-weighted impact
References
30
Percentile
97%
vs. same field & year
Citations per year
References
The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody
Lara D. Veeken · 2009 · 330 citations
Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis
Lara D. Veeken · 2010 · 324 citations
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
American Journal of Respiratory and Critical Care Medicine · 2000 · 2,622 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.